bit.bio CEO Dr. Emma Pepperell features in Life Science Daily on why AI cannot replace wet-lab experimentation or human biological discovery.
22.10.2026
Modern drug testing has a human biology problem
bit.bio CEO Emma Pepperell explores why reproducible human cell models are essential to fixing the drug discovery bottleneck and p...
bit.bio featured in Tech Nation's Future Fifty Report
bit.bio has been named one of the UK's most successful tech companies in the prestigious Future Fifty report. Discover how our syn...
Sustainability Report
Presenting our first annual sustainability report, detailing our Corporate Sustainability Strategy and progress towards our aligne...
Exclusive interview with Genetic Engineering & Biotechnology News
CEO Mark Kotter, shares insights in an exclusive interview with Genetic Engineering & Biotechnology News about the revolutionary C...
bit.bio featured in Citeline by David Wild
bit.bio featured in Citeline where David Wild writes an article about the ever-evolving landscape of synthetic biology.
BiotechTV and Brad Loncar visit to bit.bio
bit.bio featured at BiotechTV, with Brad Loncar sharing news, stories, and educational videos about the biotechnology sector.
Sifted 100 Report highlights bit.bio as one of Europe's fastest-growing companies
bit.bio featured as one of Europe's fastest-growing startups in Sifted.
European Biotechnology feature: Biology as Software
bit.bio's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to indiv...